Pharmaceuticals Stocks
171 स्टॉक ट्रैक किए में Pharmaceuticals
| टिकर | कंपनी | मार्केट कैप | P/E | संकेत |
|---|---|---|---|---|
| AARD | Aardvark Therapeutics, Inc. - Common Stock | $285.8M | — | — |
| ACB | Aurora Cannabis Inc. - Common Shares | $327.2M | — | — |
| ACRS | Aclaris Therapeutics, Inc. - Common Stock | $326.1M | — | — |
| ADIL | Adial Pharmaceuticals, Inc - Common Stock | $5.9M | — | — |
| ADXN | Addex Therapeutics Ltd - American Depositary Shares | $8.1M | — | — |
| AKAN | Akanda Corp. - Common Shares | $333K | — | — |
| ALMS | Alumis Inc. - Common Stock | $1.0B | — | — |
| AMLX | Amylyx Pharmaceuticals, Inc. - Common Stock | $1.3B | — | — |
| AMPH | Amphastar Pharmaceuticals, Inc. - Common Stock | $1.2B | 11.0 | 1 |
| AMRX | Amneal Pharmaceuticals, Inc. - Class A Common Stock | $4.0B | 671.4 | — |
| ANEB | Anebulo Pharmaceuticals, Inc. - Common Stock | $41.5M | — | — |
| ANIP | ANI Pharmaceuticals, Inc. - Common Stock | $1.8B | 43.7 | — |
| ANTX | AN2 Therapeutics, Inc. - Common Stock | $31.2M | — | — |
| AQST | Aquestive Therapeutics, Inc. - Common Stock | $788.1M | — | — |
| ARTL | Artelo Biosciences, Inc. - Common Stock | $2.5M | — | — |
| ARVN | Arvinas, Inc. - Common Stock | $761.7M | — | — |
| ASBP | Aspire Biopharma Holdings, Inc. - Common Stock | $18.3M | — | — |
| ASRT | Assertio Holdings, Inc. - Common Stock | $58.2M | — | — |
| ATAI | AtaiBeckley Inc. - Common Stock | $1.5B | — | — |
| ATHA | Athira Pharma, Inc. - Common Stock | $29.9M | — | — |
| AVDL | Avadel Pharmaceuticals plc - Ordinary Share | $2.1B | — | — |
| AVIR | Atea Pharmaceuticals, Inc. - common stock | $278.9M | — | — |
| AXSM | Axsome Therapeutics, Inc. - Common Stock | $9.2B | — | — |
| AYTU | Aytu BioPharma, Inc. - Common Stock | $26.5M | — | — |
| AZN | AstraZeneca PLC - American Depositary Shares | $213.8B | 30.6 | 3 |
| BFRI | Biofrontera Inc. - Common Stock | $6.6M | — | — |
| BGM | BGM Group Ltd. - Class A Ordinary Shares | $678.8M | — | — |
| BIOA | BioAge Labs, Inc. - Common Stock | $474.4M | — | — |
| BLTE | Belite Bio, Inc - American Depositary Shares | $5.6B | — | — |
| BTMD | Biote Corp. - Class A common stock | $118.7M | 4.1 | — |
| CALC | CalciMedica, Inc. - Common Stock | $95.0M | — | — |
| CGC | Canopy Growth Corporation - Common Shares | $574.8M | — | — |
| CGTX | Cognition Therapeutics, Inc. - Common Stock | $119.2M | — | — |
| CING | Cingulate Inc. - Common Stock | $29.3M | — | — |
| CLSD | Clearside Biomedical, Inc. - Common Stock | $4.1M | — | — |
| CMND | Clearmind Medicine Inc. - Common Shares | $2.7M | — | — |
| CNSP | CNS Pharmaceuticals, Inc. - Common Stock | $3.3M | — | — |
| CNTX | Context Therapeutics Inc. - Common Stock | $135.1M | — | — |
| COCP | Cocrystal Pharma, Inc. - Common Stock | $13.5M | — | — |
| COLL | Collegium Pharmaceutical, Inc. - Common Stock | $1.5B | 25.0 | 1 |
| CORT | Corcept Therapeutics Incorporated - Common Stock | $3.7B | 34.5 | — |
| CPIX | Cumberland Pharmaceuticals Inc. - Common Stock | $59.5M | — | — |
| CRDL | Cardiol Therapeutics Inc. - Class A Common Shares | $131.0M | — | — |
| CRMD | CorMedix Inc. - Common Stock | $916.3M | 5.6 | — |
| CRNX | Crinetics Pharmaceuticals, Inc. - Common Stock | $4.4B | — | — |
| CRON | Cronos Group Inc. - Common Share | $1.4B | 27.8 | — |
| CTNM | Contineum Therapeutics, Inc. - Common stock | $417.5M | — | — |
| CTXR | Citius Pharmaceuticals, Inc. - Common Stock | $16.1M | — | — |
| CURX | Curanex Pharmaceuticals Inc - Common Stock | $9.4M | — | — |
| CVKD | Cadrenal Therapeutics, Inc. - Common Stock | $15.9M | — | — |
| DARE | Dare Bioscience, Inc. - Common Stock | $27.6M | — | — |
| DERM | Journey Medical Corporation - Common Stock | $209.2M | — | — |
| DRRX | DURECT Corporation - Common Stock | $59.3M | — | — |
| ELVN | Enliven Therapeutics, Inc. - Common Stock | $913.9M | — | — |
| ENVB | Enveric Biosciences, Inc. - Common Stock | $2.2M | — | — |
| EOLS | Evolus, Inc. - Common Stock | $431.1M | — | — |
| ESPR | Esperion Therapeutics, Inc. - Common Stock | $884.5M | — | — |
| ETON | Eton Pharmaceuticals, Inc. - Common Stock | $453.5M | — | — |
| EVOK | Evoke Pharma, Inc. - Common Stock | $18.9M | — | — |
| EWTX | Edgewise Therapeutics, Inc. - Common Stock | $2.6B | — | — |
| EYPT | EyePoint, Inc. - Common Stock | $1.5B | — | — |
| FULC | Fulcrum Therapeutics, Inc. - Common Stock | $746.1M | — | — |
| GELS | Gelteq Limited - Ordinary Shares | $8.6M | — | — |
| GHRS | GH Research PLC - Ordinary Shares | $787.8M | — | — |
| GPCR | Structure Therapeutics Inc. - American Depositary Shares | $4.2B | — | — |
| GRCE | Grace Therapeutics, Inc. - Common Stock | $53.5M | — | — |
| HCM | HUTCHMED (China) Limited - American Depositary Shares | $18.0B | 5.0 | — |
| HIND | Vyome Holdings, Inc. - Common Stock | $19.4M | — | — |
| HITI | High Tide Inc. - Common Shares | $319.7M | — | — |
| HOTH | Hoth Therapeutics, Inc. - Common Stock | $15.4M | — | — |
| HRMY | Harmony Biosciences Holdings, Inc. - Common Stock | $2.2B | 11.6 | — |
| HROW | Harrow, Inc. - Common Stock | $1.8B | — | — |
| HROWL | Harrow, Inc. - 8.625% senior notes due 2026 | $1.8B | — | — |
| HROWM | Harrow, Inc. - 11.875% Senior Notes due 2027 | $1.8B | — | — |
| HYPD | Hyperion DeFi, Inc. - Common Stock | $29.1M | — | — |
| IMA | ImageneBio, Inc. - Common Stock | $80.8M | — | — |
| IMCC | IM Cannabis Corp. - Common Shares | $10.6M | — | — |
| INCR | Intercure Ltd. - ordinary shares | $176.9M | — | — |
| INDV | Indivior Pharmaceuticals, Inc. - Common Stock | $4.5B | 35.8 | 1 |
| INM | InMed Pharmaceuticals Inc. - Common Shares | $3.0M | — | — |
| INVA | Innoviva, Inc. - Common Stock | $1.5B | 11.7 | — |
| ITRM | Iterum Therapeutics plc - Ordinary Share | $17.7M | — | — |
| IXHL | Incannex Healthcare Inc. - Common Stock | $123.9M | — | — |
| JAGX | Jaguar Health, Inc. - Common Stock | $3.5M | — | — |
| JAZZ | Jazz Pharmaceuticals plc - Ordinary Shares | $10.3B | — | — |
| JUNS | Jupiter Neurosciences, Inc. - Common Stock | $35.1M | — | — |
| KPRX | Kiora Pharmaceuticals, Inc. - Common Stock | $7.2M | — | — |
| LBRX | LB Pharmaceuticals Inc - Common Stock | $563.2M | — | — |
| LENZ | LENZ Therapeutics, Inc. - Common Stock | $500.6M | — | — |
| LEXX | Lexaria Bioscience Corp. - Common Stock | $15.4M | — | — |
| LGND | Ligand Pharmaceuticals Incorporated - Common Stock | $3.7B | 76.6 | — |
| LPCN | Lipocine Inc. - Common Stock | $44.6M | — | — |
| LQDA | Liquidia Corporation - Common Stock | $3.0B | — | — |
| LXRX | Lexicon Pharmaceuticals, Inc. - Common Stock | $417.9M | — | — |
| LYRA | Lyra Therapeutics, Inc. - Common Stock | $5.5M | — | — |
| MAZE | Maze Therapeutics, Inc. - Common Stock | $2.0B | — | — |
| MBX | MBX Biosciences, Inc. - Common Stock | $1.4B | — | — |
| MDWD | MediWound Ltd. - Ordinary Shares | $236.7M | — | — |
| MIRA | MIRA Pharmaceuticals, Inc. - Common Stock | $63.2M | — | — |
| MIST | Milestone Pharmaceuticals Inc. - Common Shares | $172.0M | — | — |
| MNMD | Denium Therapeutics, Inc - Common Shares | $1.3B | — | — |
| NKTR | Nektar Therapeutics - Common Stock | $860.0M | — | — |
| NLSP | NLS Pharmaceutics Ltd. - Ordinary Shares | $3.2M | — | — |
| NMRA | Neumora Therapeutics, Inc. - Common Stock | $299.1M | — | — |
| NRXP | NRX Pharmaceuticals, Inc. - Common Stock | $80.2M | — | — |
| NTHI | NeOnc Technologies Holdings, Inc. - Common Stock | $198.2M | — | — |
| NTRB | Nutriband Inc. - Common Stock | $55.3M | — | — |
| OCS | Oculis Holding AG - Ordinary shares | $1.1B | — | — |
| OCUL | Ocular Therapeutix, Inc. - Common Stock | $2.6B | — | — |
| OGI | Organigram Global Inc. - Common Shares | $311.9M | — | — |
| OMER | Omeros Corporation - Common Stock | $1.2B | — | — |
| ORMP | Oramed Pharmaceuticals Inc. - Common Stock | $113.4M | 2.6 | — |
| PAHC | Phibro Animal Health Corporation - Class A Common Stock | $1.5B | 22.4 | — |
| PCRX | Pacira BioSciences, Inc. - Common Stock | $1.1B | 51.9 | — |
| PCSA | Processa Pharmaceuticals, Inc. - Common Stock | $6.5M | — | — |
| PHAT | Phathom Pharmaceuticals, Inc. - Common Stock | $1.2B | — | — |
| PHVS | Pharvaris N.V. - Ordinary Shares | $1.8B | — | — |
| PLRX | Pliant Therapeutics, Inc. - Common Stock | $75.0M | — | — |
| PPBT | Purple Biotech Ltd. - American Depositary Shares | $22.3M | — | — |
| PRFX | PRF Technologies Ltd. - Ordinary Shares | $2.5M | — | — |
| PRPH | ProPhase Labs, Inc. - Common Stock | $2.7M | — | — |
| PULM | Pulmatrix, Inc. - Common Stock | $8.1M | — | — |
| PYPD | PolyPid Ltd. - Ordinary Shares | $69.0M | — | — |
| QCLS | Q/C Technologies, Inc. - Common Stock | $16.6M | — | — |
| QNTM | Quantum Biopharma Ltd. - Class B Subordinate Voting Shares | $40.4M | — | — |
| RANI | Rani Therapeutics Holdings, Inc. - Class A Common Stock | $164.1M | — | — |
| RAPP | Rapport Therapeutics, Inc. - Common Stock | $1.4B | — | — |
| RDHL | Redhill Biopharma Ltd. - American Depositary Shares | $4.7M | — | — |
| RGC | Regencell Bioscience Holdings Limited - Ordinary Shares | $10.4B | — | — |
| RLMD | Relmada Therapeutics, Inc. - Common Stock | $354.2M | — | — |
| RPRX | Royalty Pharma plc - Class A Ordinary Shares | $22.3B | 29.2 | — |
| RVPH | Reviva Pharmaceuticals Holdings, Inc. - Common Stock | $32.1M | — | — |
| SAVA | Cassava Sciences, Inc. - Common Stock | $95.6M | — | — |
| SCLX | Scilex Holding Company - Common Stock | $103.6M | — | — |
| SCPH | scPharmaceuticals Inc. - Common Stock | $304.4M | — | — |
| SCYX | SCYNEXIS, Inc. - Common Stock | $26.5M | — | — |
| SEPN | Septerna, Inc. - Common Stock | $1.2B | — | — |
| SIGA | SIGA Technologies Inc. - Common Stock | $437.5M | 5.9 | — |
| SLGL | Sol-Gel Technologies Ltd. - Ordinary Shares | $117.4M | — | — |
| SNDL | SNDL Inc. - Common Shares | $427.4M | — | — |
| SNES | SenesTech, Inc. - Common Stock | $11.1M | — | — |
| SNOA | Sonoma Pharmaceuticals, Inc. - Common Stock | $6.2M | — | — |
| SNY | Sanofi - American Depositary Shares | $100.2B | 7.2 | 2 |
| SPRC | SciSparc Ltd. - Ordinary Shares | $4.5M | — | — |
| SUPN | Supernus Pharmaceuticals, Inc. - Common Stock | $2.8B | — | — |
| SXTC | China SXT Pharmaceuticals, Inc. - Common Stock | $185.6M | — | — |
| SXTP | 60 Degrees Pharmaceuticals, Inc. - Common Stock | $2.2M | — | — |
| TARS | Tarsus Pharmaceuticals, Inc. - Common Stock | $3.5B | — | — |
| TBPH | Theravance Biopharma, Inc. - Ordinary Shares | $948.1M | 32.3 | — |
| TELO | Telomir Pharmaceuticals, Inc. - Common Stock | $45.7M | — | — |
| TERN | Terns Pharmaceuticals, Inc. - Common Stock | $4.3B | — | — |
| TLPH | Talphera, Inc. - Common Stock | $53.1M | — | — |
| TLRY | Tilray Brands, Inc. - Common Stock | $1.0B | — | — |
| TNFA | TNF Pharmaceuticals, Inc. - Common Stock | $1.3M | — | — |
| TRAW | Traws Pharma, Inc. - Common Stock | $9.0M | — | — |
| TRVI | Trevi Therapeutics, Inc. - Common Stock | $1.6B | — | — |
| TTRX | Turn Therapeutics Inc. - Common Stock | — | — | — |
| TVRD | Tvardi Therapeutics, Inc. - Common Stock | $40.3M | — | — |
| TXMD | TherapeuticsMD, Inc. - Common Stock | $18.9M | 62.5 | — |
| UPC | Universe Pharmaceuticals Inc - Class A Ordinary Shares | $2.1M | 2.0 | — |
| VERU | Veru Inc. - Common Stock | $34.3M | — | — |
| VRCA | Verrica Pharmaceuticals Inc. - Common Stock | $78.9M | — | — |
| VRNA | Verona Pharma plc - American Depositary Shares | $9.2B | — | — |
| VTRS | Viatris Inc. - Common Stock | $14.3B | — | — |
| VTYX | Ventyx Biosciences, Inc. - Common Stock | $644.4M | — | — |
| VYNE | VYNE Therapeutics Inc. - Common Stock | $19.3M | — | — |
| WVE | Wave Life Sciences Ltd. - Ordinary Shares | $3.1B | — | — |
| XERS | Xeris Biopharma Holdings, Inc. - Common Stock | $1.3B | — | — |
| XRTX | XORTX Therapeutics Inc. - Common Stock | $5.5M | — | — |
| ZVRA | Zevra Therapeutics, Inc. - Common Stock | $504.4M | 14.3 | — |
| ZYBT | Zhengye Biotechnology Holding Limited - Ordinary Shares | $79.6M | 14.2 | — |
कोई स्टॉक आपके फ़िल्टर से मेल नहीं खाता
अपने खोज मानदंड बदलने का प्रयास करें
और स्टॉक लोड हो रहे हैं...